Market Overview

Charles River Labs Closes Purchase of Majority Ownership of Vital River

Related CRL
Jefferies Boosts Targets Across Pharmaceutical Service Stocks
Benzinga's Top Upgrades
Carl Appoints Rick Sanderson to the Board of Directors (GuruFocus)

Charles River Laboratories International, Inc. (NYSE: CRL) announced today that it has completed its acquisition of a 75% ownership of Vital River, the premier commercial provider of research models and related services in China, and a licensee of Charles River for the last ten years.

Posted-In: News M&A


Related Articles (CRL)

Around the Web, We're Loving...

Get Benzinga's Newsletters